These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10590623)

  • 21. [Blocking of carbohydrate adhesion. A new principle for therapy of many conditions?].
    Bryne M; Asheim HC; Giercksky KE
    Tidsskr Nor Laegeforen; 1995 Jun; 115(16):1957-60. PubMed ID: 7638850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Affinity and kinetics of sialyl Lewis-X and core-2 based oligosaccharides binding to L- and P-selectin.
    Beauharnois ME; Lindquist KC; Marathe D; Vanderslice P; Xia J; Matta KL; Neelamegham S
    Biochemistry; 2005 Jul; 44(27):9507-19. PubMed ID: 15996105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting selectins for the treatment of respiratory diseases.
    Romano SJ; Slee DH
    Curr Opin Investig Drugs; 2001 Jul; 2(7):907-13. PubMed ID: 11757789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocrelizumab, a humanized monoclonal antibody against CD20 for inflammatory disorders and B-cell malignancies.
    Hutas G
    Curr Opin Investig Drugs; 2008 Nov; 9(11):1206-15. PubMed ID: 18951300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. OMERACT and the clinical evaluation of new therapeutic agents: a bird's eye view. OMERACT Committee.
    Strand V
    J Rheumatol; 1993 Mar; 20(3):588-9. PubMed ID: 8478881
    [No Abstract]   [Full Text] [Related]  

  • 26. [New treatments in paediatric rheumatology: supportive measures].
    Belot A; Cimaz R
    Arch Pediatr; 2008 Jun; 15(5):870-2. PubMed ID: 18582785
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of nitric oxide in tissue destruction.
    Abramson SB; Amin AR; Clancy RM; Attur M
    Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):831-45. PubMed ID: 11812024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chronic inflammation increases the risk of cardiovascular disease in patients with rheumatoid arthritis].
    Troelsen LN; Jacobsen S
    Ugeskr Laeger; 2006 Sep; 168(39):3304-8. PubMed ID: 17032593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evaluation of drug efficacy in rheumatoid arthritis.
    Rushton A
    Methods Find Exp Clin Pharmacol; 1981; 3(5):327-35. PubMed ID: 7035771
    [No Abstract]   [Full Text] [Related]  

  • 30. Novel transdermal targeting in steroid therapy: evaluation of PK/PD profiles using an animal model of rheumatoid arthritis.
    Komuro M; Kakuo H; Sawada K; Kawaguchi Y
    Pharmazie; 2002 Feb; 57(2):147. PubMed ID: 11878193
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-inflammatory effects of leaf and twig of Tripterygium wilfordii on paw edema in mice.
    Yu L; Ao M; Wan J; Zhang Y
    Fitoterapia; 2008 Dec; 79(7-8):529-32. PubMed ID: 18672035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of polyclonal anti-thymocyte globulins on the expression of adhesion and inflammation molecules after ischemia-reperfusion injury.
    Beiras-Fernandez A; Chappell D; Hammer C; Beiras A; Reichart B; Thein E
    Transpl Immunol; 2009 Mar; 20(4):224-8. PubMed ID: 19041395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of sialyl Lewis(x) mimics as E- and P-selectin inhibitors.
    Kaila N; Thomas BE
    Med Res Rev; 2002 Nov; 22(6):566-601. PubMed ID: 12369089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rheumatoid arthritis--a risk factor of ischemic heart disease].
    Hollan I; Mikkelsen K; Førre Ø
    Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3259-62. PubMed ID: 16327849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock.
    Abdelrahman M; Sivarajah A; Thiemermann C
    Cardiovasc Res; 2005 Mar; 65(4):772-81. PubMed ID: 15721857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis.
    Clark P; Rowland SE; Denis D; Mathieu MC; Stocco R; Poirier H; Burch J; Han Y; Audoly L; Therien AG; Xu D
    J Pharmacol Exp Ther; 2008 May; 325(2):425-34. PubMed ID: 18287210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemia.
    Derhaschnig U; Pernerstorfer T; Knechtelsdorfer M; Hollenstein U; Panzer S; Jilma B
    Crit Care Med; 2003 Apr; 31(4):1108-12. PubMed ID: 12682480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Technology evaluation: ISIS-104838, OraSense.
    Kennewell P
    Curr Opin Mol Ther; 2003 Feb; 5(1):76-80. PubMed ID: 12669475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of conjugated linoleic acid on bone formation and rheumatoid arthritis.
    Hur SJ; Park Y
    Eur J Pharmacol; 2007 Jul; 568(1-3):16-24. PubMed ID: 17573069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biopharmaceuticals in the treatment of rheumatoid arthritis].
    Baslund B; Bendtzen K
    Ugeskr Laeger; 2008 Jun; 170(24):2108-10. PubMed ID: 18572481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.